Search Results for "somatotropin"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for somatotropin. Results 1 to 3 of 3 total matches.
See also: Saizen, Somatropin

Cool.click: A Needle-free Device For Growth Hormone Delivery

   
The Medical Letter on Drugs and Therapeutics • Jan 08, 2001  (Issue 1095)
of Saizen (recombinant somatotropin − Serono). Somatotropin is used for long-term treatment of children ...
A new needle-free system (cool.click) has been approved by the FDA for subcutaneous delivery of Saizen (recombinant somatotropin - Serono). Somatotropin is used for long-term treatment of children with growth failure due to inadequate secretion of endogenous growth hormone. Children with growth hormone deficiency require injections daily or several times weekly for many years.
Med Lett Drugs Ther. 2001 Jan 8;43(1095):2-3 |  Show IntroductionHide Introduction

Growth-Hormone-Releasing-Factor for Growth Hormone Deficiency

   
The Medical Letter on Drugs and Therapeutics • Jan 01, 1999  (Issue 1043)
Somatotropin 0.3 mg/kg/week in 7 doses Humatrope (Lilly) 19,740 Saizen (Serono) 19,740 Norditropin (Novo ...
Sermorelin acetate, a synthetic form of human growth-hormone-releasing factor has been approved by the FDA for treatment of idiopathic growth hormone deficiency in children with growth failure.
Med Lett Drugs Ther. 1999 Jan 1;41(1043):2-3 |  Show IntroductionHide Introduction

Octreotide - A Synthetic Somatostatin

   
The Medical Letter on Drugs and Therapeutics • Jul 14, 1989  (Issue 796)
portal circulation where it acts as a release-inhibiting factor on thyrotropin and somatotropin (growth ...
Octreotide acetate (Sandostatin - Sandoz), a synthetic octapeptide that mimics the actions of somatostatin, was recently approved by the US Food and Drug Administration for symptomatic treatment of patients with metastatic carcinoid or VIPomas (vasoactive intestinal peptide-secreting tumors).
Med Lett Drugs Ther. 1989 Jul 14;31(796):66-8 |  Show IntroductionHide Introduction